Other OTC - Delayed Quote USD

Thermic Sciences International (ENDO)

0.0001 0.0000 (0.00%)
As of April 18 at 12:31 PM EDT. Market Open.
Loading Chart for ENDO
DELL
  • Previous Close 0.0001
  • Open 0.0001
  • Bid --
  • Ask --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0001 - 0.0010
  • Volume 336
  • Avg. Volume 0
  • Market Cap (intraday) 961,278
  • Beta (5Y Monthly) 2.16
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Thermic Sciences International develops and sells hemp based products. The company offers hemp formulation-based health and wellness solutions, as well as cosmeceuticals, nutraceuticals, and food brands. It also provides over the counter products for hair and skin include Hempery miracle oil, a skin care solution; Hemp milk body wash, a creamy soap; Hemp lotion bars for moisturizing hands and body; Hemp rose soap; and Hemtastique lip and body balms. The company also develops products for ailments, such as acquired immune deficiency syndrome/human immunodeficiency virus, asthma, cancer, glaucoma, influenza, pain management, and post-traumatic stress disorder. It distributes its products in the United States, Canada, Colombia, Ireland, India, China, Japan, South Korea, and Afghanistan through online and in retail stores. The company was formerly known as OmniCanna Health Solutions, Inc. Thermic Sciences International was incorporated in 1969 and is based in Colorado Springs, Colorado.

www.omnicanna.com

--

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: ENDO

Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ENDO
40.00%
S&P 500
4.59%

1-Year Return

ENDO
80.00%
S&P 500
20.07%

3-Year Return

ENDO
99.83%
S&P 500
19.20%

5-Year Return

ENDO
99.50%
S&P 500
71.73%

Compare To: ENDO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ENDO

Valuation Measures

As of 4/19/2024
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    -0.87

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -5.43M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    59

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

People Also Watch